Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists breed pigs resistant to deadly virus
Pig
PRRS virus causes reproductive failure and can also cause respiratory tract illness in young pigs.

Discovery could have enormous implications for pig producers

Scientists at the University of Missouri have bred the first pigs which are resistant porcine reproductive and respiratory syndrome (PRRS) virus.

Using gene editing techniques the researchers were able to develop a pig that lacked the protein CD163, which is necessary for the PRRS virus to infect the pig's cells and cause disease.

Recent results show the gene-edited animals are resistant to infection from the virus. They do not get ill and have no signs of virus in their bodies. Kristin Whitworth, co-author of the study, explains:

“We edited the gene that makes the CD163 protein so the pigs could no longer produce it.

“We then infected these pigs and control pigs; the pigs without CD163 never got sick. This discovery could have enormous implications for pig producers and the food industry throughout the world.”

While the pigs that didn't produce the CD163 didn't get sick,the researchers noted no other changes in their development, compared to pigs that produce the protein.

Following these promising early results, the University of Missouri has signed an exclusive global licensing agreement for future commercialisation of virus resistant pigs with the Genus, plc.

If the development stage is successful, the commercial partner will seek any necessary approvals and registration from governments before a wider market release.

Welcoming the news, professor Bruce Whitelaw, head of division of developmental biology at the Roslin Institute said: “Although the research is still at an early stage, this paper points to what can be achieved using the new genome editing technology and could be a game changer for the pig industry.

"It has the potential to benefit the entire pork food chain from the farmer through to the consumer.”

Gene-editing involves modifying individual letters of an animal's genetic code. It is different from traditional GM techniques, because no new information is inserted into the DNA.

PRRS virus causes reproductive failure and can also cause respiratory tract illness in young pigs. There is currently no cure or adequate treatment.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.